NCT00467389View on ClinicalTrials.gov

Use of Donepezil for Treatment of Cocaine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Cocaine Abuse and Dependence
Interventions
DRUG

Donepezil, 5 mg daily

This is a commercially available cholinesterase inhibitor that is approved for use in Alzheimer's disease.

OTHER

Oral Placebo

Inactive Comparator with Similar Appearance to Active Medication

Trial Locations (1)

64128

VA Medical Center, Kansas City

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00467389 - Use of Donepezil for Treatment of Cocaine Dependence | Biotech Hunter | Biotech Hunter